Stock Scorer

Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings, Inc. reported revenue of 20.2M USD for the quarter ending 30 June 2026, down 48.5% from 39.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 20.2M -48.5%
Gross Profit Q2 '26 · ending 30 June 2026 18.4M —
Operating Income Q2 '26 · ending 30 June 2026 -58.5M —
Net Income Q2 '26 · ending 30 June 2026 -46.7M —
Cost of Revenue Q2 '26 · ending 30 June 2026 1.7M —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -44.3M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -46.9M —
Shares Outstanding Q2 '26 · ending 30 June 2026 62.1M +14.5%
EPS Q2 '26 · ending 30 June 2026 -5.01 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 170.2M-315.3M-312.8M-178.7M
20242024-12-31 227M-559.8M-547M-382.1M
20232023-12-31 251.5M-864.4M-892.9M-336.3M
20222022-12-31 477.7M-2.2B-2.1B-304.5M
20212021-12-31 313.8M-1.8B-1.8B-310.3M
20202020-12-31 76.7M-137M-126.6M-193.7M
20192019-12-31 54.2M-71.6M-119.3M-66.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3020.2M
Q1 '262026-03-3119.5M
Q4 '252025-12-3133.4M
Q3 '252025-09-3038.8M
Q2 '252025-06-3039.1M
Q1 '252025-03-3138.2M
Q4 '242024-12-3143.8M
Q3 '242024-09-3089M
Q2 '242024-06-3056.2M
Q1 '242024-03-3137.9M
Q4 '232023-12-3134.8M
Q3 '232023-09-3055.4M
Q2 '232023-06-3080.6M
Q1 '232023-03-3180.7M
Q4 '222022-12-3198.3M
Q3 '222022-09-3066.4M
Q2 '222022-06-30144.6M
Q1 '222022-03-31168.4M
Q4 '212021-12-31148.5M
Q3 '212021-09-3077.6M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-3018.4M
Q1 '262026-03-3116.4M
Q2 '252025-06-3033.8M
Q1 '252025-03-3134.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-58.5M
Q1 '262026-03-31-71.4M
Q4 '252025-12-31-70.8M
Q3 '252025-09-30-90M
Q2 '252025-06-30-58.2M
Q1 '252025-03-31-81M
Q4 '242024-12-31-103.6M
Q3 '242024-09-30-55.2M
Q2 '242024-06-30-222.9M
Q1 '242024-03-31-178M
Q4 '232023-12-31-178.1M
Q3 '232023-09-30-286.4M
Q2 '232023-06-30-184.2M
Q1 '232023-03-31-215.7M
Q4 '222022-12-31-230.9M
Q3 '222022-09-30-654.9M
Q2 '222022-06-30-647.8M
Q1 '222022-03-31-675.4M
Q4 '212021-12-31-1.7B
Q3 '212021-09-30-26.7M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-46.7M
Q1 '262026-03-31-82.6M
Q4 '252025-12-31-80.8M
Q3 '252025-09-30-80.8M
Q2 '252025-06-30-60.3M
Q1 '252025-03-31-91M
Q4 '242024-12-31-107.5M
Q3 '242024-09-30-56.4M
Q2 '242024-06-30-217.2M
Q1 '242024-03-31-165.9M
Q4 '232023-12-31-211.7M
Q3 '232023-09-30-302.9M
Q2 '232023-06-30-173.3M
Q1 '232023-03-31-205M
Q4 '222022-12-31-175.5M
Q3 '222022-09-30-670.1M
Q2 '222022-06-30-668.8M
Q1 '222022-03-31-590.5M
Q4 '212021-12-31-1.6B
Q3 '212021-09-30-101.9M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-301.7M
Q1 '262026-03-313.1M
Q2 '252025-06-305.4M
Q1 '252025-03-314.1M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-44.3M
Q1 '262026-03-31-46.7M
Q4 '252025-12-31-47.7M
Q3 '252025-09-30-31.6M
Q2 '252025-06-30-40.3M
Q1 '252025-03-31-51.5M
Q4 '242024-12-31-42.4M
Q3 '242024-09-30-103.5M
Q2 '242024-06-30-84.4M
Q1 '242024-03-31-89.3M
Q4 '232023-12-31-57.8M
Q3 '232023-09-30-73.6M
Q2 '232023-06-30-73.5M
Q1 '232023-03-31-90.6M
Q4 '222022-12-31-104.5M
Q3 '222022-09-30-28.4M
Q2 '222022-06-30-99.4M
Q1 '222022-03-31-19.9M
Q4 '212021-12-31-165.5M
Q3 '212021-09-30-5.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-46.9M
Q1 '262026-03-31-48.6M
Q4 '252025-12-31-47.7M
Q3 '252025-09-30-31.6M
Q2 '252025-06-30-40.3M
Q1 '252025-03-31-59.1M
Q4 '242024-12-31-56.1M
Q3 '242024-09-30-118.6M
Q2 '242024-06-30-111.4M
Q1 '242024-03-31-96M
Q4 '232023-12-31-61.3M
Q3 '232023-09-30-77.9M
Q2 '232023-06-30-87.1M
Q1 '232023-03-31-110M
Q4 '222022-12-31-130.2M
Q3 '222022-09-30-41.8M
Q2 '222022-06-30-109M
Q1 '222022-03-31-23.5M
Q4 '212021-12-31-170.7M
Q3 '212021-09-30-10.7M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3062.1M
Q1 '262026-03-3159.6M
Q3 '252025-09-3055.6M
Q2 '252025-06-3054.9M
Q1 '252025-03-3154.2M
Q3 '242024-09-3052.2M
Q2 '242024-06-3051.4M
Q1 '242024-03-3150.1M
Q3 '232023-09-3048.8M
Q2 '232023-06-301.9B
Q1 '232023-03-311.9B
Q3 '222022-09-301.6B
Q2 '222022-06-301.6B
Q1 '222022-03-311.6M
Q3 '212021-09-301.3B
Q2 '212021-06-301.3B

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-5.01
Q1 '262026-03-31-5.36
Q4 '252025-12-31-5.65
Q3 '252025-09-30-6.19
Q2 '252025-06-30-5.82
Q1 '252025-03-31-8.95
Q4 '242024-12-31-10.59
Q3 '242024-09-30-12.91
Q2 '242024-06-30-18.04
Q1 '242024-03-31-13.90
Q4 '232023-12-31-10.69
Q3 '232023-09-30-55.42
Q2 '232023-06-30-49.62
Q1 '232023-03-31-49.94
Q4 '212021-12-31-1.39